ETUSD Superintendent Sara Haflic speaks with TME about the proposed Phone Free Schools Act To see full stories with photos, ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

The tumor microenvironment (TME) is a major obstacle that limits effective cancer treatments. Various cells around the tumor promote immunosuppression and | Immunology ...

Significant advancements have been made in targeted cancer therapy in recent years, yet the challenge of overcoming resistance to these treatments in solid tumors persists. The tumor microenvironment ...

Randy Sweis, MD, First Author, Assistant Professor, University of Chicago Medicine Comprehensive Cancer Center The tumor microenvironment (TME) plays a critical role in predicting response to ...

Immunotherapy holds great promise for the future of cancer treatment. By harnessing a patient’s own immune system to target ...

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’Topline safety data of SB101 Phase 1 study expected ...

MBW Reacts is a series of analytical commentaries from Music Business Worldwide written in response to major recent ...

NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% ...

One strategy tumors use to ensure survival involves interfering with our inherent immune response.  Effective anti-tumor ...

Tumor microenvironment (TME) and treatment response were assessed using gene set enrichment analysis (GSEA), ESTIMATE, CIBERSORT, and the immunophenoscore (IPS) algorithm. The results showed a risk ...